← Eichor
Condition: Soft Tissue Sarcoma Sts Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Soft Tissue Sarcoma Sts

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Phase 1 · 1 location(s) · Novartis Pharmaceuticals · NCT07630961Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT07648069BAL Fluid Biomarkers in Sarcoma
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06815666PET-imaging of Two Vartumabs in Patients With Solid Tumors
EARLY_Phase 1 · 1 location(s) · Var2 Pharmaceuticals · NCT06645808A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage
Phase 2 · 1 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT04166006Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Phase 2 · 2 location(s) · Oslo University Hospital · NCT07173972tTF-NGR Randomized Study - STS
Phase 3 · 9 location(s) · Universität Münster · NCT05597917Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma
NA · 1 location(s) · Shandong Cancer Hospital and Institute · NCT06980259Exercise and Soft Tissue Sarcoma
NA · 1 location(s) · Duke University · NCT04921917Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT06905132Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
NA · 1 location(s) · Institut Claudius Regaud · NCT06967961SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Phase 1/Phase 2 · 1 location(s) · Sarcoma Oncology Research Center, LLC · NCT03138161A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional
Phase 1/Phase 2 · 11 location(s) · GI Innovation, Inc. · NCT05824975Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)
NA · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT05761054Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
Phase 2 · 1 location(s) · Asociación Europea y Latinoamericana SELNET para la Investig · NCT07032285SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radi
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07049848Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study
NA · 2 location(s) · Sun Yat-sen University · NCT06848582Fluorescence-Guided Optimization of Sarcoma Margins
NA · 2 location(s) · University of Aarhus · NCT07134192Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy
NA · 15 location(s) · Centre Leon Berard · NCT05944913Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Phase 1 · 8 location(s) · Novartis Pharmaceuticals · NCT07261631Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774729SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Management in S
NA · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT06889532Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05926700A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patie
EARLY_Phase 1 · 1 location(s) · Pure Biologics S.A. · NCT06700070Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Phase N/A · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT07432932Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07602049
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.